WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016.
about
Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.Parallel Evolution of Group B Streptococcus Hypervirulent Clonal Complex 17 Unveils New Pathoadaptive Mutations.Immunization with a Latch Peptide Provides Serotype-Independent Protection against Group B Streptococcus Infection in Mice.Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates?Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children.Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001-2015.Diminished capsule exacerbates virulence, blood brain barrier penetration, intracellular persistence and antibiotic evasion of hyperhemolytic Group B Streptococcus.Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.Potential targets for next generation anti-microbial glycoconjugate vaccines.Seroprevalence of Opsonophagocytic Antibodies against Serotype Ia, Ib, II, III, and V Group B Streptococcus among Korean Population.Importance of Functional Assessment of Immunity against Group B Streptococcus.
P2860
Q39386700-0B1E6C23-8BFA-4178-9B0B-8ED1E9A460B8Q40047331-259D4EBD-7CB3-49F7-BD80-5119174D5C9AQ45934269-1013B393-8A77-42A2-96AC-475A4141521FQ46372104-F8A81128-3C02-476C-99A2-2112CD7A25C3Q46954965-AA4B110D-D0AC-4BA3-A5EE-70ED09DA9358Q47546256-5243B5C4-7F0D-4BF6-A7A1-8AB4A3773BB7Q47883436-6EE19E0B-50B8-419C-BD9F-4F2609446E64Q48053443-CDEC40C4-2661-4903-8F2A-D898148C960FQ52624533-D7B8E25B-2605-43EE-B975-0C4397FDF59DQ53701548-C459F482-CEB4-4799-8C0D-28CCB26B841AQ55011294-C6B25183-4766-4AEA-A41F-A41B8014B312Q55200331-690611A8-49A9-4E36-B68E-D29638D765AD
P2860
WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
WHO consultation on group B St ...... ting held on 27-28 April 2016.
@en
WHO consultation on group B St ...... ting held on 27-28 April 2016.
@nl
type
label
WHO consultation on group B St ...... ting held on 27-28 April 2016.
@en
WHO consultation on group B St ...... ting held on 27-28 April 2016.
@nl
prefLabel
WHO consultation on group B St ...... ting held on 27-28 April 2016.
@en
WHO consultation on group B St ...... ting held on 27-28 April 2016.
@nl
P2093
P1433
P1476
WHO consultation on group B St ...... eting held on 27-28 April 2016
@en
P2093
Ajoke Sobanjo-Ter Meulen
Carol J Baker
David C Kaslow
Johan Vekemans
Mark R Alderson
Miwako Kobayashi
Shabir A Madhi
Stephanie J Schrag
P304
P356
10.1016/J.VACCINE.2016.12.029
P407
P577
2016-12-22T00:00:00Z